1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE:TGIF) (OTCQX:TGIFF), a vertically integrated cannabis consumer packaged goods company that owns licensed cultivation and manufacturing assets to support its brands, is pleased to announce that the Company received a permanent Occupancy Permit for its cultivation facility, thereby completing the last step of the construction project initiated to expand cannabis cultivation in Las Vegas, Nevada.

1933 Industries Cultivation Facility in Las Vegas (CNW Group/1933 Industries Inc.)

“The completion of our new cultivation facility marks an incredible milestone for our Alternative Medicine Association (AMA) subsidiary”, said Company CEO Mr. Chris Rebentisch. “We are extremely pleased to be able to move into our new facility and begin operations. This is a 5x increase in flower cultivation to fuel the growth of our proprietary AMA branded products and deliver on our white label contracts. Securing a consistent supply of raw materials will have a positive effect on our margins and future revenues and will enable us to attract additional partners.”


Facility Highlights

Total Size: The 67,750 sq. ft. building is spread over two floors and is zoned as a Light Manufacturing – M-1 facility. This will be one of the largest indoor facilities in Las Vegas.

Cultivation Space: The facility was designed to house 15 bloom rooms, 3 veg rooms and 1 clone room. The initial operating canopy will be 22,100 sq. ft. with the ability to expand into another 18,000 sq. ft., if needed.

Cultivation Cycle: On average, the grow cycle is approximately 15 weeks. Once capacity is reached with all 15 flower rooms filled, the Company expects to harvest approximately 1,500 plants every 14 days for a projected 700-800 lbs. of flower per month.

Fertigation System: A Link 4 system controls mixing nutrients (mixing up to 15 different nutrients automatically) and plant watering to each room, according to a pre-defined formula, corresponding to each growth stage. The system controls HVAC, humidification and dehumidification, and oxygen levels with built-in safety alarms in each grow room.

Mr. Tim Spencer, Director of Cultivation remarked, “Link 4 integrates all the environmental systems, allowing us to track all input data points in the cultivation process. We can then drive our crops with data rather than subjective opinions and truly maximize the potential of the facility”.

Consistent Water Supply:  The facility includes a 12,000gal Reverse Osmosis Storage system. This feature is significant as the Las Vegas municipal water has a high mineral content and cultivating with clean water is essential for plant health. In addition, the volume of water stored allows the Company to mitigate the risk of a service interruption.

Plant Health and Disease Management: The HVAC System (a Daikin Variable Refrigerant Volume) multi-split air conditioner allows each room to function independently, with no duct-work built between grow rooms. Having a true “sealed” room increases Co2 levels without waste and allows for effective plant quarantining should a disease outbreak arise.

Lighting System: An eFinity 1,100w DEHPS dimmable electronic ballast – from 1,000w to 600w – provides better control of the light spectrum for each stage of the plant. Utilizing a lighting controller provides the ability to ramp up the light intensity in the morning to mimic a natural “sunrise” and slowly turn down the light towards “sunset”, thus giving the plants a more natural lighting pattern and producing the largest yields possible.

Next Steps

Upon securing the transfer of its cultivation license to the new facility, 26 plant varieties, 5,000 clones, and 200 moms will be transported to propagate the new facility and commence operations.

To view our new cultivation facility, please visit:
https://youtu.be/AofQKcImVJM

About 1933 Industries Inc.

1933 Industries Inc. is a vertically integrated cannabis company with operations in the United States and Canada. 1933 Industries owns licensed medical and adult-use cannabis cultivation and production assets, proprietary hemp-based, CBD infused products, CBD extraction services and a specialized cannabis advisory firm. Our proprietary brands include AMA, Canna Hemp™, Canna HempX™, Canna Fused™, Canna Hemp Paws™, and Nineteen 33 THC. Birdhouse Skateboards™, OG DNA Genetics, Denver Dab Co., The Real Kurupt’s Moon Rocks and Gotti’s Gold under licensing agreements.

About Canna Hemp™
Canna Hemp™ CBD Relief Cream was named “Best Topical” by Leafy’s Best in State: The Top State Specific Products and Experiences of 2018. Infused’s award-winning transdermal Pain Relief Cream delivers fast-acting targeted relief to areas of discomfort, combating inflammation, arthritis joint pain, backaches, muscles spasms, strains, bruises, cramps, and headaches.
http://www.cannahemp.com
https://www.leafly.com/news/strains-products/best-in-state-2018-nevada-cannabis

About Canna HempX™
Canna Hemp X™ was named “Best Topicals for Pain” by Herb’s Guide to the Best Cannabis Products on the Planet. Canna Hemp X™ is a CBD sports recovery cream for athletes to help focus on recovery and wellness. From soothing pain, aiding with muscle spasms, healing assistance for bruises, injuries, or arthritis relief, Canna Hemp X™ bridges the gap between recovery and top performance.
http://www.cannahempx.com

https://herb.co/learn/best-cannabis-products/

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct.  Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com.   1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Click here to connect with 1933 Industries Inc. (CSE:TGIF, FWB:1QF, OTC:VPGDF) for an Investor Presentation.

Source: www.prnewswire.com

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less